Alzheimer's Memory Center
Matthew, North Carolina 28105
0 studies enrolling now · 2 studies all time
What they study most
Alzheimer Disease
Studies at this site
Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease
— Completed
Open-label Extension for Phase 3 Clinical Trials of Simufilam
— Stopped early